AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients with PE.
Learn More
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
The AlphaVac system is an off the shelf, easy to assemble, emergent mechanical aspiration device, allowing for efficient procedure time…
Today, localized therapy options are limited in providing physicians and patients with a customizable and confident treatment. Most options come…
Engineered with your practice and your patients in mind, The Auryon System is designed with industry-leading technology and features that…
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.
GAME ON. Our FY24 Global Sales Meeting has kicked off! This week will be full of fantastic physician panels, educational sessions, and inspiring opportunities for growth. Thank you, Field Sales Teams, for all you do.
Learn more:
Risk Info: https://lnkd.in/gFNG_pA
BioSentry Tract Sealant System
The BioSentry tract sealant system is the first biopsy sealant system of its kind designed specifically to address ...
lnkd.in
The BioSentry Tract Sealant System is designed specifically to address the issues of biopsy-related pneumothorax. An MD Anderson study noted a drastic reduction in pneumothorax & chest tube placements allowing patients & physicians to feel comfortable and confident post-biopsy.
AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.
Latham, NY (HQ)
Glens Falls, NY (Manufacturing)
Queensbury, NY (Manufacturing)
Marlborough, MA (R&D)
Amsterdam, NL (International HQ)
São Paulo, BR (Brazil Office)
Oakville, CA (Canada Office)
Hong Kong, HK (Asia Pacific Regional Office)
Rehovot, IL (Israel Office)
